Authors: Rover, S Wichmann, J Jenck, F Adam, G Cesura, AM

Citation: S. Rover et al., ORL1 receptor ligands: Structure-activity relationships of 8-cycloalkyl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-ones, BIOORG MED, 10(8), 2000, pp. 831-834

Authors: Wichmann, J Adam, G Rover, S Hennig, M Scalone, M Cesura, AM Dautzenberg, FM Jenck, F

Citation: J. Wichmann et al., Synthesis of (1S,3aS)-8-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one, a potent and selective orphanin FQ (OFQ) receptor agonist with anxiolytic-like properties, EUR J MED C, 35(9), 2000, pp. 839-851

Authors: Rover, S Adam, G Cesura, AM Galley, G Jenck, F Monsma, FJ Wichmann, J Dautzenberg, FM

Citation: S. Rover et al., High-affinity, non-peptide agonists for the ORL1 (orphanin FQ/nociceptin) receptor, J MED CHEM, 43(7), 2000, pp. 1329-1338

Authors: Wichmann, J Adam, G Rover, S Cesura, AM Dautzenberg, FM Jenck, F

Citation: J. Wichmann et al., 8-acenaphthen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one derivativesas orphanin FQ receptor agonists, BIOORG MED, 9(16), 1999, pp. 2343-2348

Authors: Rover, S Wipf, P

Citation: S. Rover et P. Wipf, Synthesis and applications of fluorous silyl protecting groups with improved acid stability, TETRAHEDR L, 40(31), 1999, pp. 5667-5670

Authors: Konig, W Rover, S

Citation: W. Konig et S. Rover, Interview with Stefan Rover, WIRTSCHAFTS, 40(6), 1998, pp. 536-537